Clinical Trial of Elemene Injection/Elemene Oral Emulsion in Combination with Systematic Chemotherapy including Oxaliplatin in the First -line treatment of advanced primary liver cancer. Patients with advanced primary liver cancer will be enrolled in the trial , then separated randomly into two group. One group treated with the Elemene Injection/Elemene Oral Emulsion in Combination with Systematic Chemotherapy including Oxaliplatin , another group treated with Systematic Chemotherapy including Oxaliplatin. The purpose of the study is to evaluate the effect and safety of the Elemene Injection/Elemene Oral Emulsion in Combination with Systematic Chemotherapy including Oxaliplatin in the First -line treatment of advanced primary liver cancer.
| Study Type : |
Interventional (Clinical Trial) |
| Estimated Enrollment : |
150 participants |
| Allocation: |
Randomized |
| Intervention Model: |
Parallel Assignment |
| Intervention Model Description: |
One group treated with the Elemene Injection/Elemene Oral Emulusion in Combination with Systematic Chemotherapy including Oxaliplatin , another group treated with Systematic Chemotherapy including Oxaliplatin. |
| Masking: |
None (Open Label) |
| Primary Purpose: |
Treatment |
| Official Title: |
Clinical Trial of Elemene Injection/Elemene Oral Emulsion in Combination With Systematic Chemotherapy Including Oxaliplatin in the First -Line Treatment of Advanced Primary Liver Cancer |
| Actual Study Start Date : |
November 28, 2016 |
| Estimated Primary Completion Date : |
May 28, 2019 |
| Estimated Study Completion Date : |
November 27, 2019 |
Contacts
Locations
| The First Hospital of Hebei Medical University |
| Shijiazhuang, Hebei, China, 050000 |
| Contact: Yonghui An |
